Condition

Osteopenia

ClinicalTrials.gov condition label

Clinical trials35

Recruiting3

Common interventions25

Lead sponsors shown15

Clinical trials

35 shown

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)NCT07083557 · 2027-01-01

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)NCT07412782 · 2025-12-04

Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive IndividualsNCT06762730 · 2024-12-09

Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMDNCT06828211 · 2024-09-09

ACTIVE_NOT_RECRUITING

The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical TrialNCT06050577 · 2024-06-07

ACTIVE_NOT_RECRUITING

A Study on the Prevention and Treatment of GIOP With EldecalcitolNCT06385093 · 2024-06-01

Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMDNCT05779566 · 2023-01-09

Prevalence of Osteosarcopenic Obesity in Older AdultsNCT04288401 · 2020-02-25

Bone Health and Vitamin D StatusNCT01634607 · 2019-12-01

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)NCT03549689 · 2019-08-01

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture RiskNCT05701254 · 2019-06-18

Incidence of HANA Conditions in HIV-infected IndividualsNCT03483584 · 2018-04-06

Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal WomenNCT02355821 · 2015-04-01

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to RaltegravirNCT01902186 · 2014-09-01

Study of Growth Hormone and Bone in ObesityNCT01724489 · 2013-08-01

Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)NCT01870557 · 2013-03-01

Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityNCT01679899 · 2012-12-01

Effects of Denosumab on the Pharmacokinetics of EtanerceptNCT01294397 · 2011-03-01

Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)NCT01228318 · 2011-01-01

Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerNCT01277562 · 2010-11-01

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone HomeostasisNCT01020045 · 2010-10-01

Study of an Intervention to Improve Problem List Accuracy and UseNCT01105923 · 2010-05-01

Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term SteroidsNCT01287533 · 2010-04-01

Study of Bone Disease in Older HIV-infected AdultsNCT00935935 · 2009-12-01

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossNCT00925600 · 2009-11-30

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast CancerNCT00859703 · 2009-11-01

Switch From Tenofovir to Raltegravir for Low Bone Mineral DensityNCT00939874 · 2009-10-01

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?NCT00766532 · 2009-01-01

Melatonin Osteoporosis Prevention StudyNCT01152580 · 2008-09-01

Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityNCT00102908 · 2005-05-01

Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)NCT00231127 · 2005-04-01

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast CancerNCT00089661 · 2004-10-01

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthNCT00069004 · 2003-10-01

Bone Mineral Density (BMD) in HIV InfectionNCT00146094 · 2003-03-01

Bone Loss in Premenopausal Women With DepressionNCT00006180 · 2000-08-10

Common interventions

Leading sponsors

Amgen3 Emory University2 National Institute of Allergy and Infectious Diseases (NIAID)2 Bettina Mittendorfer1 Brigham and Women's Hospital1 Catharina Ziekenhuis Eindhoven1 Centro de Diabetes Curitiba Ltda1 Chinese SLE Treatment And Research Group1 Chinese University of Hong Kong1 City of Hope Medical Center1 Creighton University1 Duquesne University1 Fundación para la Investigación del Hospital Clínico de Valencia1 Giovanni Di Perri1 Hadassah Medical Organization1

Trial status mix

COMPLETED22

UNKNOWN4

RECRUITING3

TERMINATED3

ACTIVE_NOT_RECRUITING2

WITHDRAWN1

Phase mix

PHASE48

NA6

PHASE24

PHASE33

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.